Lymph node evaluation in early-stage colon cancer

Clinical Colorectal Cancer

Volumn 7, Issue 4, 2008, Pages 240-246

  Govindarajan, Anand ^a   Baxter, Nancy N ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Lymph node staging; Lymphadenectomy; Metastases; Micrometastasis; Sentinel lymph node biopsy

Indexed keywords

BREAST CANCER; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; COLON CANCER; HUMAN; LYMPHADENECTOMY; LYMPHATIC DRAINAGE; MEDICAL ASSESSMENT; MELANOMA; OUTCOME ASSESSMENT; REVIEW; SENTINEL LYMPH NODE BIOPSY;

EID: 49149111493     PISSN: 15330028     EISSN: None     Source Type: Journal    
DOI: 10.3816/CCC.2008.n.031     Document Type: Review

References (78)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007; 57:43-66.
2. Nelson H, Petrelli N, Carlin A, et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 2001; 93:583-96.
3. Compton C. Colorectal carcinoma: Diagnostic, prognostic, and molecular features. Modern Pathology 2003; 16:376-88.
4. Benson AB, 3rd, Schrag D, Somerfield MR, et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 2004; 22:3408-19.
5. Figueredo A, Fine S, Maroun J, et al. Adjuvant therapy for stage III colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group. Cancer Prev Control 1997; 1:304-19.
6. Figueredo A, Germond C, Maroun J, et al. Adjuvant therapy for stage II colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group. Cancer Prev Control 1997; 1:379-92.
7. Caplin S, Cerottini JP, Bosman FT, et al. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis. Cancer 1998; 83:666-72.
8. Baxter NN, Virnig DJ, Rothenberger DA, et al. Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst 2005; 97:219-25.
9. Cianchi F, Palomba A, Boddi V, et al. Lymph node recovery from colorectal tumor specimens: recommendation for a minimum num-ber of lymph nodes to be examined. World J Surg 2002; 26:384-9.
10. Gumus M, Yumuk PF, Atalay G, et al. What is the optimal number of lymph nodes to be dissected in colorectal cancer surgery? Tumori 2005; 91:168-72.
11. Berberoglu U. Prognostic significance of total lymph node number in patients with T1-4N0M0 colorectal cancer. Hepatogastroenterology 2004; 51:1689-93.
12. Bui L, Rempel E, Reeson D, et al. Lymph node counts, rates of positive lymph nodes, and patient survival for colon cancer surgery in Ontario, Canada: a population-based study. J Surg Oncol 2006; 93:439-45.
13. Carloss H, Huang B, Cohen A, et al. The impact of number of lymph nodes removed on five-year survival in stage II colon and rectal cancer. J Ky Med Assoc 2004; 102:345-7.
14. Cserni G, Vinh-Hung V, Burzykowski T. Is there a minimum number of lymph nodes that should be histologically assessed for a reliable nodal staging of T3N0M0 colorectal carcinomas? J Surg Oncol 2002; 81:63-9.
15. Goldstein NS. Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol 2002; 26:179-89.
16. Jestin P, Pahlman L, Glimelius B, et al. Cancer staging and survival in colon cancer is dependent on the quality of the pathologists' specimen examination. Eur J Cancer 2005; 41:2071-8.
17. Law CH, Wright FC, Rapanos T, et al. Impact of lymph node retrieval and pathological ultra-staging on the prognosis of stage II colon cancer. J Surg Oncol 2003; 84:120-6.
18. Le Voyer TE, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 2003; 21:2912-9.
19. Prandi M, Lionetto R, Bini A, et al. Prognostic evaluation of stage B colon cancer patients is improved by an adequate lymphadenectomy: results of a secondary analysis of a large scale adjuvant trial. Ann Surg 2002; 235:458-63.
20. Ratto C, Sofo L, Ippoliti M, et al. Accurate lymph-node detection in colorectal specimens resected for cancer is of prognostic significance. Dis Colon Rectum 1999; 42:143-54; discussion 54-8.
21. Sarli L, Bader G, Iusco D, et al. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer. Eur J Cancer 2005; 41:272-9.
22. Swanson RS, Compton CC, Stewart AK, et al. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 2003; 10:65-71.
23. Wong JH, Bowles BJ, Bueno R, et al. Impact of the number of negative nodes on disease-free survival in colorectal cancer patients. Dis Colon Rectum 2002; 45:1341-8.
24. Yoshimatsu K, Ishibashi K, Umehara A, et al. How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate. Hepatogastroenterology 2005; 52:1703-6.
25. Chang GJ, Rodriguez-Bigas MA, Skibber JM, et al. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst 2007; 99:433-41.
26. Leibl S, Tsybrovskyy O, Denk H. How many lymph nodes are necessary to stage early and advanced adenocarcinoma of the sigmoid colon and upper rectum? Virchows Arch 2003; 443:133-8.
27. Wong JH, Severino R, Honnebier MB, et al. Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol 1999; 17:2896-900.
28. Wong SL, Ji H, Hollenbeck BK, et al. Hospital lymph node examination rates and survival after resection for colon cancer. JAMA 2007; 298:2149-54.
29. George S, Primrose J, Talbot R, et al. Will Rogers revisited: prospective observational study of survival of 3592 patients with colorectal cancer according to number of nodes examined by pathologists. Br J Cancer 2006; 95:841-7.
30. Johnson PM, Porter GA, Ricciardi R, et al. Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol 2006; 24:3570-5.
31. Kawamura YJ, Umetani N, Sunami E, et al. Effect of high ligation on the long-term result of patients with operable colon cancer, particularly those with limited nodal involvement. Eur J Surg 2000; 166:803-7.
32. Iversen LH, Harling H, Laurberg S, et al. Influence of caseload and surgical speciality on outcome following surgery for colorectal cancer: a review of evidence. Part 2: long-term outcome. Colorectal Dis 2007; 9:38-46.
33. Wright FC, Law CH, Last L, et al. Lymph node retrieval and assessment in stage II colorectal cancer: a population-based study. Ann Surg Oncol 2003; 10:903-9.
34. Johnson PM, Malatjalian D, Porter GA. Adequacy of nodal harvest in colorectal cancer: a consecutive cohort study. J Gastrointest Surg 2002; 6:883-88; discussion 9-90.
35. Miller EA, Woosley J, Martin CF, et al. Hospital-to-hospital variation in lymph node detection after colorectal resection. Cancer 2004; 101:1065-71.
36. Gorog D, Nagy P, Peter A, et al. Influence of obesity on lymph node recovery from rectal resection specimens. Pathol Oncol Res 2003; 9:180-3.
37. Pages F, Berger A, Camus M, et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 2005; 353:2654-66.
38. Galon J, Costes A, Sanchez-Cabo F, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313:1960-4.
39. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127:392-9.
40. Metrie AE, van Rij AM, Phillips LV, et al. Diagnostic use of the sentinel node in colon cancer. Dis Colon Rectum 2001; 44:410-7.
41. Patten LC, Berger DH, Rodriguez-Bigas M, et al. A prospective evaluation of radiocolloid and immunohistochemical staining in colon carcinoma lymphatic mapping. Cancer 2004; 100:2104-9.
42. Saha S, Dan AG, Berman B, et al. Lymphazurin 1% versus 99mTc sulfur colloid for lymphatic mapping in colorectal tumors: a comparative analysis. Ann Surg Oncol 2004; 11:21-6.
43. Bilchik AJ, Nora D, Tollenaar RA, et al. Ultrastaging of early colon cancer using lymphatic mapping and molecular analysis. Eur J Cancer 2002; 38:977-85.
44. Bilchik AJ, Saha S, Wiese D, et al. Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial. J Clin Oncol 2001; 19:1128-36.
45. Wong JH, Johnson DS, Namiki T, et al. Validation of ex vivo lymphatic mapping in hematoxylin-eosin node-negative carcinoma of the colon and rectum. Ann Surg Oncol 2004; 11:772-7.
46. Wong JH, Steineman S, Calderia C, et al. Ex vivo sentinel node mapping in carcinoma of the colon and rectum. Ann Surg 2001; 233:515-21.
47. Baton O, Lasser P, Sabourin JC, et al. Ex vivo sentinel lymph node study for rectal adenocarcinoma: preliminary study. World J Surg 2005; 29:1166-70, discussion 71.
48. Bell SW, Mourra N, Flejou JF, et al. Ex vivo sentinel lymph node mapping in colorectal cancer. Dis Colon Rectum 2005; 48:74-9.
49. Broderick-Villa G, Amr D, Haigh PI, et al. Ex vivo lymphatic mapping: a technique to improve pathologic staging in colorectal cancer. Am Surg 2004; 70:937-41.
50. Demirbas S, Ince M, Baloglu H, et al. Should sentinel lymph node mapping be performed for colorectal cancer? Turk J Gastroenterol 2004; 15:39-44.
51. Fitzgerald TL, Khalifa MA, Al Zahrani M, et al. Ex vivo sentinel lymph node biopsy in colorectal cancer: a feasibility study. J Surg Oncol 2002; 80:27-32; discussion 3.
52. Smith FM, Coffey JC, Khasri NM, et al. Sentinel nodes are identifiable in formalin-fixed specimens after surgeon-performed ex vivo sentinel lymph node mapping in colorectal cancer. Ann Surg Oncol 2005; 12:504-9.
53. Wood TF, Saha S, Morton DL, et al. Validation of lymphatic mapping in colorectal cancer: in vivo, ex vivo, and laparoscopic techniques. Ann Surg Oncol 2001; 8:150-7.
54. Bilchik AJ, DiNome M, Saha S, et al. Prospective multicenter trial of staging adequacy in colon cancer: preliminary results. Arch Surg 2006; 141:527-33; discussion 33-4.
55. Stojadinovic A, Nissan A, Protic M, et al. Prospective randomized study comparing sentinel lymph node evaluation with standard pathologic evaluation for the staging of colon carcinoma: results from the United States Military Cancer Institute Clinical Trials Group Study GI-01. Ann Surg 2007; 245:846-57.
56. Bertagnolli M, Miedema B, Redston M, et al. Sentinel node staging of resectable colon cancer: results of a multicenter study. Ann Surg 2004; 240:624-8; discussion 8-30.
57. Redston M, Compton CC, Miedema BW, et al. Analysis of micrometastatic disease in sentinel lymph nodes from resectable colon cancer: results of Cancer and Leukemia Group B Trial 80001. J Clin Oncol 2006; 24:878-83.
58. Bembenek AE, Rosenberg R, Wagler E, et al. Sentinel lymph node biopsy in colon cancer: a prospective multicenter trial. Ann Surg 2007; 245:858-63.
59. Saha S, Bilchik A, Wiese D, et al. Ultrastaging of colorectal cancer by sentinel lymph node mapping technique-a multicenter trial. Ann Surg Oncol 2001; 8:94S-8S.
60. Wood TF, Spirt M, Rangel D, et al. Lymphatic mapping improves staging during laparoscopic colectomy for cancer. Surg Endosc 2001; 15:715-9.
61. Esser S, Reilly WT, Riley LB, et al. The role of sentinel lymph node mapping in staging of colon and rectal cancer. Dis Colon Rectum 2001; 44:850-4; discussion 4-6.
62. Cserni G, Vajda K, Tarjan M, et al. Nodal staging of colorectal carcinomas from quantitative and qualitative aspects. Can lymphatic mapping help staging? Pathol Oncol Res 1999; 5:291-6.
63. Joosten JJ, Strobbe LJ, Wauters CA, et al. Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma. Br J Surg 1999; 86:482-6.
64. Saha S, Seghal R, Patel M, et al. A multicenter trial of sentinel lymph node mapping in colorectal cancer: prognostic implications for nodal staging and recurrence. Am J Surg 2006; 191:305-10.
65. Paramo JC, Summerall J, Poppiti R, et al. Validation of sentinel node mapping in patients with colon cancer. Ann Surg Oncol 2002; 9:550-4.
66. Viehl CT, Hamel CT, Marti WR, et al. Identification of sentinel lymph nodes in colon cancer depends on the amount of dye injected relative to tumor size. World J Surg 2003; 27:1285-90.
67. Turner RR, Nora DT, Trocha SD, et al. Colorectal carcinoma nodal staging. Frequency and nature of cytokeratin-positive cells in sentinel and nonsentinel lymph nodes. Arch Pathol Lab Med 2003; 127:673-9.
68. Greenson JK, Isenhart CE, Rice R, et al. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer 1994; 73:563-9.
69. Liefers GJ, Cleton-Jansen AM, van de Velde CJ, et al. Micrometastases and survival in stage II colorectal cancer. N Engl J Med 1998; 339:223-8.
70. Jeffers MD, O'Dowd GM, Mulcahy H, et al. The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma. J Pathol 1994; 172:183-7.
71. Adell G, Boeryd B, Franlund B, et al. Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes' B colorectal carcinoma: an immunohistochemical study. Eur J Surg 1996; 162:637-42.
72. Oberg A, Stenling R, Tavelin B, et al. Are lymph node micrometastases of any clinical significance in Dukes Stages A and B colorectal cancer? Dis Colon Rectum 1998; 41:1244-9.
73. Broll R, Schauer V, Schimmelpenning H, et al. Prognostic relevance of occult tumor cells in lymph nodes of colorectal carcinomas: an immunohistochemical study. Dis Colon Rectum 1997; 40:1465-71.
74. Choi HJ, Choi YY, Hong SH. Incidence and prognostic implications of isolated tumor cells in lymph nodes from patients with Dukes B colorectal carcinoma. Dis Colon Rectum 2002; 45:750-5; discussion 5-6.
75. Iddings D, Ahmad A, Elashoff D, et al. The prognostic effect of micrometastases in previously staged lymph node negative (NO) colorectal carcinoma: a meta-analysis. Ann Surg Oncol 2006; 13:1386-92.
76. Bilchik AJ, Hoon DS, Saha S, et al. Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial. Ann Surg 2007; 246:568-75; discussion 75-7.
77. Bembenek A, Rau B, Moesta T, et al. Sentinel lymph node biopsy in rectal cancer - not yet ready for routine clinical use. Surgery 2004; 135:498-505; discussion 6-7.
78. Braat AE, Oosterhuis JW, Moll FC, et al. Sentinel node detection after preoperative short-course radiotherapy in rectal carcinoma is not reliable. Br J Surg 2005; 92:1533-8.